<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To assess the clinical characteristics and outcome of patients with cardiac <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease(BD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Medical charts of 20 cardiac BD patients admitted in Peking Union Medical College Hospital from June 1996 to June 2011 were systematically reviewed, including demographic data, clinical features, laboratory and histopathology findings and outcome </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Patients age ranged 19~57 yrs[mean (35±10) yrs], included 17 males and 3 females </plain></SENT>
<SENT sid="3" pm="."><plain>Six (30%) of them did not fulfill the ISG criteria at cardiac <z:hpo ids='HP_0003674'>onset</z:hpo>, and fourteen (70%) of them experienced <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Echocardiography findings included <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> (n=7), and aortic valve involvement with left ventricular enlargement and severe <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> (n=13) </plain></SENT>
<SENT sid="5" pm="."><plain>Eight patients underwent surgery before efficient <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> treatment, and five (62.5%) underwent re-operation due to recurrence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> or valvular dehiscence and severe paravalvular leakage </plain></SENT>
<SENT sid="6" pm="."><plain>Histopathology findings revealed predominantly inflammatory cells infiltration, <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> and fibrous tissue formation </plain></SENT>
<SENT sid="7" pm="."><plain>After initiation of <z:chebi fb="0" ids="8382">prednisone</z:chebi> plus <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi>, patients were followed up for 6~42 months (mean 14.8±9.9 months), the <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> disappeared or decreased in size in five cases, remained stable after surgery in the other two cases, and the <z:hpo ids='HP_0001635'>heart failure</z:hpo> disappeared in <z:hpo ids='HP_0000001'>all</z:hpo> patients with aortic involvement </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Cardiac BD affects males more than females, and is prone to delayed diagnosis because some patients do not have typical clinical manifestations at cardiac <z:hpo ids='HP_0003674'>onset</z:hpo>; <z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> plus <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> reduce the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> and improve <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> in cardiac BD, whereas surgery alone does not lead to complete resolution </plain></SENT>
</text></document>